Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

RLAY

Relay Therapeutics, Inc.

CIK 0001812364 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$19.44
↓ 0.26 (-1.32%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Technicals; Risks: Fundamentals, Options

Key stats

Market Cap
$4.26B
P/E Ratio
-14.89
EPS
-1.61
Dividend Yield
Not covered
52W Position
90%
Beta
1.61

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
4.79
P/S
411.65
EV/Revenue
399.94
ROE
-32.1%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 90%
$3.31$21.27

Latest Financials

2025-12-31 FY
Revenue
$15.36M
Net Income
-$276.48M
Total Assets
$621.33M
Free Cash Flow
-$235.87M

Recent news